510(k) K802886

NUCLI-PAP TM-(I125)-PAP RADIOIMMUNOAS- by Nuclear Diagnostics, Inc. — Product Code JFH

K802886 is an FDA 510(k) premarket notification submitted by Nuclear Diagnostics, Inc. for the device "NUCLI-PAP TM-(I125)-PAP RADIOIMMUNOAS-". The FDA issued a decision of Substantially Equivalent on Jan 28, 1981. The device falls under product code JFH (Acid Phosphatase (Prostatic), Tartrate Inhibited), a Class II device regulated under 21 CFR 862.1020. Nuclear Diagnostics, Inc. has 23 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jan 28, 1981
Date Received
Nov 17, 1980
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Acid Phosphatase (Prostatic), Tartrate Inhibited
Device Class
Class II
Regulation Number
862.1020
Review Panel
CH
Submission Type
510(k) Exempt

Need the full FDA record for Nuclear Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K802886. Report a data issue: hello@regdatalab.com.